UC Davis Awarded Five Therapy Development Stem Cell Grants The California Institute for Regenerative Medicine approved research planning grants for five University of California, Davis (UC Davis) Health System teams that are working to develop human clinical trials to treat illnesses such as Huntington’s disease, vascular disease, osteoporosis, HIV/AIDS and airway disease in children. [University of California, Davis School of Medicine] Press Release
Mesoblast in Position of Considerable Strength Regenerative medicine company, Mesoblast Limited, provided its full year financial results. The company stated that it had substantial funds of $263.2 million at 30 June 2011. [Mesoblast Limited] Press Release
Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.